ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The Health Benefits of Manuka Honey

Increase Your Magnesium Intake

Vitamin D supplementation could ease IBS symptoms

Top Tips to Boost Your Immunity

11 Amazing Health Benefits of Using Baking Soda

Nicotinamide riboside shows promise for treatment of Alzheimer’s disease

Exercise, calcium, vitamin D, and other factors linked with fewer injurious falls

Vitamin D3 Is a Powerhouse for Your Heart

Curcumin Supplementation May Impart Long-Term Cognitive Benefits

Rhodiola — A Powerful Adaptogen That Boosts Vitality and Performance, Eases Depression and Combats B...

 
Print Page
Email Article

New Data Projects Alzheimer's Disease Could Affect 16 Million by 2050

  [ 107 votes ]   [ Discuss This Article ]
www.ProHealth.com • July 26, 2002


New research released at the 8th International Conference on Alzheimer's Disease and Related Disorders, indicates that the prevalence of the disease in the United States will increase from 4.5 million in 2000 to between 11 and 16 million by the year 2050.

The study, conducted by Denis A. Evans, M.D., of the Rush Institute on Healthy Aging and the Rush Alzheimer's Disease Center in Chicago, bases its findings on figures from the Chicago Health and Aging Project, a large study supported by the National Institutes of Health, and population figures from the 2000 U.S. Census.

Projections from this study are consistent with, though slightly higher than, projections from a similar study using 1990 U.S. Census data conducted by Evans 10 years ago.

The Alzheimer's disease incidence data represent a population-based study of 6,158 persons and projects low, middle and high estimates of people with the disease in three age categories: 65-74, 75-84, and 85+. The study's findings show little change in the youngest age group, but significant increases in the two older groups.

Evans attributes the surge in the two older age groups to the size of the population moving into the age for Alzheimer onset within the next 10 years and the life span of that population extending beyond 85 years of age.

"The study shows growth in the current Alzheimer population over the next 50 years, with the most significant surge in the 85 and older age group, or the oldest of the old," Evans said.

According to Alzheimer's Disease International, there are 18 million people worldwide with dementia. The World Health Reports 2001, from the World Health Organization, estimated that there may be as many as 37 million people worldwide with dementia.

It is estimated that costs for treating Alzheimer's disease in the U.S. alone are at least $100 billion annually. A study released last month estimated the cost to U.S. businesses - in lost productivity and absenteeism of employees who care for family members with Alzheimer's disease - to be $61 billion a year.

Alzheimer's Association Interim President and CEO Stephen McConnell, Ph.D., warned of the ramifications for health care systems around the world and cited the scope of research on the cost of Alzheimer's being presented at the conference as further evidence that Alzheimer's is a looming global crisis.

"The study on Alzheimer prevalence and those on the costs related to Alzheimer's underscore the urgent need for more research into the causes, prevention and treatment of this devastating disease," McConnell said. "We must find the answers before these projections become a reality. That's why in the United States the Alzheimer's Association is urging the U.S. Congress to increase federal funding of Alzheimer research to $1 billion."



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Vitamin D3 Extreme™ Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

SAD? Coping with Seasonal Affective Disorder SAD? Coping with Seasonal Affective Disorder
Reversing Neurodegeneration with a New Magnesium Compound Reversing Neurodegeneration with a New Magnesium Compound
"It's Not Easy Being Green" - But It Is Healthy
Vital Molecule Increases Cellular Energy and Improves Cognitive Function Vital Molecule Increases Cellular Energy and Improves Cognitive Function
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map